Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guilingji Capsule for Idiopathic OAT
NCT05320536Phase 4Unknown
- Sponsor
- Jinling Hospital
- Start
- Dec 2021
- Primary completion
- Jun 2022
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of Guilingji in idiopathic oligoasthenoteratozoospermia (iOAT), sponsored by Jinling Hospital. Status: unknown.
02
Drugs
Guilingji
03
Conditions
idiopathic oligoasthenoteratozoospermia (iOAT)
Beyond the preview
Go deeper on NCT05320536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05320536.